Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00058526
Status:
COMPLETED
Last Update Posted:
2017-05-15
First Post:
2003-04-07
Brief Title:
A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-03-20
Start Date Type:
ACTUAL
Primary Completion Date:
2006-09-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-09-06
Completion Date Type:
ACTUAL
First Submit Date:
2003-04-07
First Submit QC Date:
April 8 2003
Study First Post Date:
2003-04-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-12
Last Update Post Date:
2017-05-15
Last Update Post Date Type:
ACTUAL